Insights : sector - Osborne Clarke

Life Sciences and Healthcare

Learn more about this sector

Article list

Life Sciences and Healthcare

EU pharma package widens the Bolar exemption and moves the line on patent infringement

Pricing and reimbursement procedures, tender bids and third-party suppliers will fall outside patent infringement. Originators lose an important hook for...

02/11/2026

Read time 4m

Life Sciences and Healthcare

Licences in Insolvency: German Law, the New EU Directive, and What Licensors and Licensees Must Do Now

Germany's long-standing failure to legislate on the treatment of licences in insolvency is not merely a technical legal problem. It...

28/10/2026

Read time 8m

Regulatory Outlook

Products | UK Regulatory Outlook October 2026

General/digital products updates: UK: Law Commission launches consultation on product liability reform | Private member's bill would introduce mandatory safety...

28/10/2026

Read time 12m

Competition, antitrust and trade

The French Competition Authority imposes a penalty on a merger below the thresholds under the rules on anti-competitive practices

Following on from the CJEU's Towercast judgment, the French Competition Authority (FCA) has, for the first time in France, imposed...

23/10/2026

Read time 3m

Life Sciences and Healthcare

Interview: Dr Florian Reiling for Life Science Legal Strategy

09/10/2026

Read time 1m

Regulatory Outlook

Products | UK Regulatory Outlook September 2026

General/digital products: UK updates: Tobacco and vapes: retail licensing, packaging and age of sale update | OPSS publishes guidance on...

28/09/2026

Read time 12m

Life Sciences and Healthcare

UK life sciences head into autumn as policy and regulatory reforms race to match tech advances

MHRA progresses on AI, gene therapy and medicines regulation as the UK positions itself as a global sector leader

17/09/2026

Read time 8m

Regulatory and compliance

EU clamps down on meat names for plant-based and cultivated alternatives

New rules for the use of meat terms will force plant-based and cultivated producers to rebrand ahead of a 2029...

11/09/2026

Read time 4m

Life Sciences and Healthcare

English High Court grants dynamic website blocking order to tackle counterfeit medicines

Creative solution to IP and regulatory breaches gives life sciences companies greater control over unlawful online sales

24/08/2026

Read time 4m

Life Sciences and Healthcare

European courts and regulators target the intersection of regulatory and patent trends in the life sciences

The Tecfidera case and provisional pharma reform agreement put regulatory exclusivity and patent protection in focus

03/08/2026

Read time 8m

Life Sciences and Healthcare

EU pharma regulators publish annual AI observatory report

The EMA and HMA signal a shift from AI adoption to implementation, with coordinated AI pharma guidance underway

31/07/2026

Read time 5m

Life Sciences and Healthcare

CJEU judgment redraws the perimeter of EU medical device rules

Ruling on unprinted patient wristbands tightens qualification, marketing claims and distributor duties

31/07/2026

Read time 8m

Regulatory Outlook

Products | UK Regulatory Outlook July 2026

General/digital products updates: UK Government sets out regulatory 'sandbox' plans under forthcoming Regulating for Growth Bill | UK Government launches...

29/07/2026

Read time 13m

Life Sciences and Healthcare

Spain rewrites pricing and funding rules for medical products and devices

The Ministry of Health is driving the most significant reform for medicines within the Spanish NHS in more than a...

22/07/2026

Read time 3m

Life Sciences and Healthcare

Reimbursement in Poland — What's changing?

The PPO President formally transmitted a comprehensive review of accession conditions to the Minister of Justice the first structured inter-institutional...

10/07/2026

Read time 9m

View all insights

Life Sciences and Healthcare

EU pharma package widens the Bolar exemption and moves the line on patent infringement

Pricing and reimbursement procedures, tender bids and third-party suppliers will fall outside patent infringement. Originators lose an important hook for...

02/11/2026

Read time 4m

Life Sciences and Healthcare

Licences in Insolvency: German Law, the New EU Directive, and What Licensors and Licensees Must Do Now

Germany's long-standing failure to legislate on the treatment of licences in insolvency is not merely a technical legal problem. It...

28/10/2026

Read time 8m

Regulatory Outlook

Products | UK Regulatory Outlook October 2026

General/digital products updates: UK: Law Commission launches consultation on product liability reform | Private member's bill would introduce mandatory safety...

28/10/2026

Read time 12m

Competition, antitrust and trade

The French Competition Authority imposes a penalty on a merger below the thresholds under the rules on anti-competitive practices

Following on from the CJEU's Towercast judgment, the French Competition Authority (FCA) has, for the first time in France, imposed...

23/10/2026

Read time 3m

Life Sciences and Healthcare

Interview: Dr Florian Reiling for Life Science Legal Strategy

09/10/2026

Read time 1m

Regulatory Outlook

Products | UK Regulatory Outlook September 2026

General/digital products: UK updates: Tobacco and vapes: retail licensing, packaging and age of sale update | OPSS publishes guidance on...

28/09/2026

Read time 12m

Life Sciences and Healthcare

UK life sciences head into autumn as policy and regulatory reforms race to match tech advances

MHRA progresses on AI, gene therapy and medicines regulation as the UK positions itself as a global sector leader

17/09/2026

Read time 8m

Regulatory and compliance

EU clamps down on meat names for plant-based and cultivated alternatives

New rules for the use of meat terms will force plant-based and cultivated producers to rebrand ahead of a 2029...

11/09/2026

Read time 4m

Life Sciences and Healthcare

English High Court grants dynamic website blocking order to tackle counterfeit medicines

Creative solution to IP and regulatory breaches gives life sciences companies greater control over unlawful online sales

24/08/2026

Read time 4m

Life Sciences and Healthcare

European courts and regulators target the intersection of regulatory and patent trends in the life sciences

The Tecfidera case and provisional pharma reform agreement put regulatory exclusivity and patent protection in focus

03/08/2026

Read time 8m

Life Sciences and Healthcare

EU pharma regulators publish annual AI observatory report

The EMA and HMA signal a shift from AI adoption to implementation, with coordinated AI pharma guidance underway

31/07/2026

Read time 5m

Life Sciences and Healthcare

CJEU judgment redraws the perimeter of EU medical device rules

Ruling on unprinted patient wristbands tightens qualification, marketing claims and distributor duties

31/07/2026

Read time 8m

Regulatory Outlook

Products | UK Regulatory Outlook July 2026

General/digital products updates: UK Government sets out regulatory 'sandbox' plans under forthcoming Regulating for Growth Bill | UK Government launches...

29/07/2026

Read time 13m

Life Sciences and Healthcare

Spain rewrites pricing and funding rules for medical products and devices

The Ministry of Health is driving the most significant reform for medicines within the Spanish NHS in more than a...

22/07/2026

Read time 3m

Life Sciences and Healthcare

Reimbursement in Poland — What's changing?

The PPO President formally transmitted a comprehensive review of accession conditions to the Minister of Justice the first structured inter-institutional...

10/07/2026

Read time 9m

View all insights

Will James

Partner, International Life Sciences and Healthcare Sector Co-Leader

+44 207 105 7774 Email Will Full bio UK

Dr. Andrea Schmoll

Partner, International Life Sciences and Healthcare Sector Co-Leader

+49 221 5108 4408 Email Andrea Full bio Germany

Thomas Devred

Partner, Head of Life Sciences and Healthcare - Paris

+ 33 1 84 82 41 06 Email Thomas Full bio France

Silvia Steiner

Partner

+34 93 419 18 18 Email Silvia Full bio Spain

Maria Grazia Medici

Partner, Head of Life Sciences & Healthcare

+39 06 3269 5015 Email Maria Grazia Full bio Italy

Herke van Hulst

Co-chair of the International Council, Partner, Lawyer

+31 207 02 86 72 Email Herke Full bio The Netherlands

Catherine Wolfenden

Partner, Disputes & Risk Practice Group Head

+44 117 917 3600 Email Catherine Full bio UK

Marcus Vass

Partner, Head of Digital Health

UK +44 2071 057 634 Email Marcus Full bio UK

Rafael García del Poyo

Partner

+34 91 576 44 76 Email Rafael Full bio Spain

Dr Agnieszka Sztoldman

Partner, Head of IP

+48 503 973 626 Email Dr Agnieszka Full bio Poland

Tim Harris

Partner

+44 207 105 7144 Email Tim Full bio UK

Giulia Verusio

Senior Associate

+39 06 3269 5008 Email Giulia Full bio Italy

J. Carlos Suárez

Counsel

+39 02 5413 1772 Email J. Carlos Full bio Italy

David Haex

Co-Managing Partner

+32 2 515 9322 Email David Full bio Belgium

Xavier Pican

Partner, IP/IT/Data

+33 1 84 82 45 88 Email Xavier Full bio France

Julia Kaufmann, LL.M.

Partner

+49 89 5434 8068 Email Julia Full bio Germany

Dr Flemming Moos

Partner, Specialist lawyer for IT law

+49 40 55436 4054 Email Flemming Full bio Germany

Dr Tim Reinhard

Partner, Head of Intellectual Property Germany, Wirtschaftsmediator (MuCDR)

+49 89 5434 8024 Email Tim Full bio Germany

Dr Martin Sundermann

Partner, Wirtschaftsmediator (MuCDR)

+49 89 5434 8026 Email Martin Full bio Germany

Steve Wilson

Managing Partner

+1 917 545 3672 Email Steve Full bio US

Jordi Casas

Co-Managing Partner

+34 93 419 18 18 Email Jordi Full bio Spain

Vladimir Murovec

Counsel, Head of Life Sciences Regulatory

+32 472 607 628 Email Vladimir Full bio Belgium

Hadrien Chef

Partner

+32 2 515 93 24 Email Hadrien Full bio Belgium

View all

Belgium

China

France

Germany

India

Italy

Luxembourg

The Netherlands

Poland

Singapore

Spain

Sweden

UK

USA

Insights

Life Sciences and Healthcare

Article list

Connect with one of our experts

Sign up for our newsletter

Legal Notice